e-learning
resources
Madrid 2019
Monday, 30.09.2019
Identification of new targets and therapeutic strategies for lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NF-kB ACTIVATION IN CYSTIC FIBROSIS: THE DREAM OF A20
G. Momtazi (Belfast, United Kingdom), A. Elbanna (Belfast, United Kingdom), S. Finnegan (Belfast, United Kingdom), M. Héritier (Belfast, United Kingdom), L. Lavery (Belfast, United Kingdom), K. Mccollum (Belfast, United Kingdom), J. Naranjo (Madrid, Spain), B. Schock (Belfast, United Kingdom)
Source:
International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Session:
Identification of new targets and therapeutic strategies for lung disease
Session type:
Thematic Poster
Number:
2371
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Momtazi (Belfast, United Kingdom), A. Elbanna (Belfast, United Kingdom), S. Finnegan (Belfast, United Kingdom), M. Héritier (Belfast, United Kingdom), L. Lavery (Belfast, United Kingdom), K. Mccollum (Belfast, United Kingdom), J. Naranjo (Madrid, Spain), B. Schock (Belfast, United Kingdom). NF-kB ACTIVATION IN CYSTIC FIBROSIS: THE DREAM OF A20. 2371
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
BLOCKAGE OF TLR4 OR NLRP3 INHIBITS IL-1ß ACTIVATION IN RESPONSE TO INTERMITTENT HYPOXIA
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020
PRO-INFLAMMATORY ACTIVITY AND OXIDATIVE STRESS ON A LINE OF CYSTIC FIBROSIS (CF) HUMAN RESPIRATORY EPITHELIUM
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
NOVEL KLF4-FOXO1 INTERACTOME IN LUNG FIBROBLASTS:REGULATOR OF MYOFIBROBLASTS IN HYPEROXIA-INDUCED LUNG INJURY
Source: Virtual Congress 2020 – Airway development in health and disease
Year: 2020
TRANSCRIPTOMIC PROFILING REVEALS M1-HIGH TUMOUR ASSOCIATED MACROPHAGES THAT ORCHESTRATE THE ADAPTIVE ANTI-TUMOUR RESPONSE IN HUMAN LUNG CANCER
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017
E-CADHERIN GENE PROMOTER METHYLATION IN PEDIATRIC ASTHMA PATHOGENESIS AND CLINICS
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018
EVALUATION OF THE PALLIATIVE CRITERIA IN IDIOPATHIC PULMONARY FIBROSIS
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
ROLE OF TRAIL IN THE PATHOGENESIS OF BRONCHOPULMONARY DYSPLASIA (BPD)
Source: International Congress 2017 – Molecular biology of normal and abnormal lung development
Year: 2017
OSTEOPONTIN PROTECTS AGAINST LUNG INJURY CAUSED BY EXTRACELLULAR HISTONES
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
SKELETAL MUSCLE DYSFUNCTION AND BODY COMPOSITION ALTERATIONS IN NON-CYSTIC FIBROSIS BRONCHIECTASIS PATIENTS: GENDER DIFFERENCES
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020
PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
INTERMITTENT HYPOXIA AND FRAGMENTATION OF THE DREAM INDUCE THE APPEARANCE OF HEPATIC STEATOSIS
Source: International Congress 2019 – Pathophysiological aspects of obstructive sleep apnoea from sea level to high altitude
Year: 2019
THE PROGRESSION OF IMMUNE DISORDERS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE IS ASSOCIATED WITH CHANGES IN LEUKOCYTE MEMBRANE FATTY ACID COMPOSITION
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
PLEURO-PULMONARY COMPLICATIONS IN PATIENTS WITH CYSTIC FIBROSIS
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY.
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
GLN27GLU POLYMORPHISM IN THE ß2-ADRENERGIC RECEPTOR GENE AND THE RISK OF ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
CYTOKINE RESPONSE AND CD14CD282 CELLS IN NON-SMOKERS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
SERUM OSMOLARITY IS ASSOCIATED WITH SEVERITY OF OBSTRUCTIVE SLEEP APNEA SYNDROME: A NOVEL RISK FACTOR FOR CARDIOVASCULAR DISEASE
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018
“ASSESSING THE TREATMENT EFFECT FROM MULTIPLE TRIALS IN IDIOPATHIC PULMONARY FIBROSIS.” L. RICHELDI. EUR RESPIR REV 2012; 21: 147–151.
Source: Eur Respir Rev 2012 21:263
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept